Treatment of pyoderma gangrenosum with cyclosporine: results in seven patients.

The mainstay of therapy for pyoderma gangrenosum has been corticosteroids, but many patients respond poorly. During the past 2 years we have treated seven patients who had pyoderma gangrenosum with cyclosporine after their condition proved resistant to conventional therapy. No evidence of permanent toxicity from cyclosporine was detected and treatment with other immunosuppressive agents was discontinued in five of seven cases. Tuberculosis was reactivated in one patient. Three patients had a remission, three had an intermediate response, and one did not respond. These results indicate that cyclosporine is useful in the treatment of patients with refractory pyoderma gangrenosum and suggest an immune mechanism in the pathogenesis of this disorder.
AuthorsG Elgart, P Stover, K Larson, C Sutter, S Scheibner, B Davis, J Bass
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 24 Issue 1 Pg. 83-6 (Jan 1991) ISSN: 0190-9622 [Print] UNITED STATES
PMID1999537 (Publication Type: Journal Article)
Chemical References
  • Cyclosporins
  • Adult
  • Aged
  • Aged, 80 and over
  • Cyclosporins (adverse effects, therapeutic use)
  • Female
  • Foot Dermatoses (drug therapy, pathology)
  • Gangrene
  • Humans
  • Male
  • Middle Aged
  • Pyoderma (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: